Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) dropped 7.8% on Wednesday following insider selling activity. The company traded as low as $10.76 and last traded at $10.82. Approximately 170,975 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 674,948 shares. The stock had previously closed at $11.73. […]
Piper Sandler assumed coverage on shares of Tango Therapeutics (NASDAQ:TNGX – Free Report) in a report released on Monday, MarketBeat.com reports. The firm issued an overweight rating and a $18.00 price target on the stock. Separately, B. Riley began coverage on shares of Tango Therapeutics in a research report on Friday, December 8th. They set […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) CEO Barbara Weber sold 4,681 shares of the business’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $12.56, for a total value of $58,793.36. Following the transaction, the chief executive officer now owns 1,539,624 shares of […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) insider Adam Crystal sold 4,288 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $12.56, for a total transaction of $53,857.28. Following the transaction, the insider now directly owns 123,561 shares of the […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report)’s share price shot up 5.5% during trading on Wednesday . The stock traded as high as $12.04 and last traded at $11.99. 97,015 shares were traded during trading, a decline of 88% from the average session volume of 778,927 shares. The stock had previously closed at $11.36. […]